Registered Kenya · PPB

CEFRACEF 250 CAPSULE

CEFRADINE MONOHYDRATE BP EQ.TO CEFRADINE

CTD2378 250 MG/TABLET antiinfectives for systemic use

What it does

Cefradine is an antibiotic that helps fight bacterial infections in the body.

Commonly used for: bacterial infections, respiratory tract infections, urinary tract infections, skin infections

Read more in plain English ↓

Plain-language summary for general understanding - not medical advice. Always follow your pharmacist/doctor.

Ask about this medicine

Answers come only from this medicine's registration record, BNF monograph and interaction data - not medical advice.

Hard to find? We help patients in Kenya source rare medicines. We don't sell or dispense medicines - licensed pharmacies do.

Source this medicine

Registration & product details

Registration no.
CTD2378
Registration date
-
Expiry date
-
Status
Registered
Active ingredient
CEFRADINE MONOHYDRATE BP EQ.TO CEFRADINE
Dosage form
250 MG/TABLET
Strength
-
Pack size
-
Therapeutic class
-
ATC class (WHO)
J01DB - First-generation cephalosporins
RxNorm RxCUI
2239
Manufacturer / MAH
Biovail Health
Applicant / LTR
-
Country of origin
FOREIGN

Source: Pharmacy and Poisons Board · fetched 2026-01-28 20:42:04 · updated 2026-07-26 11:32:38

Drug Interactions

3
Check interactions

Pharmacodynamic Warnings

Cefradine appears in TABLE 2: Drugs that cause nephrotoxicity

Unknown (3)

Cephalosporins - increases exposure

Leflunomideispredictedtoincreasetheexposureto cephalosporins(cefaclor).oTheoretical

Unknown Theoretical

Cephalosporins - increases exposure

Nitisinone is predicted to increase the exposure to cephalosporins (cefaclor).

Unknown Study

Cephalosporins - increases exposure

Teriflunomide is predicted to increase the exposure to cephalosporins (cefaclor).

Unknown Study

Data from BNF 85 (British National Formulary). This is not a substitute for professional medical advice. Matched via: class

Disclaimer: This information is sourced from Pharmacy and Poisons Board (Kenya). Always consult a qualified healthcare professional before using any medication.

About this medicine

Cefradine is an antibiotic that helps fight bacterial infections in the body.

What it treats

  • bacterial infections
  • respiratory tract infections
  • urinary tract infections
  • skin infections

How it works

Cefradine works by killing bacteria or preventing their growth, helping the body to recover from infections.

Who it's for

Cefradine is suitable for people with bacterial infections, as directed by a healthcare provider.

Drug class

Cephalosporins

Cautions

  • • Be cautious if you are taking other medications that may harm the kidneys.

AI-assisted summary grounded in BNF data - general information only, not medical advice. Always confirm with your pharmacist or doctor.

Clinical monograph: Cefradine

BNF-referenced

Cefradine is a first generation cephalosporin antibiotic with a spectrum of activity primarily against Gram-positive bacteria, and some Gram-negative bacteria. It is commonly used to treat various bacterial infections, including respiratory tract infections, skin infections, and urinary tract infections. Cefradine works by inhibiting bacterial cell wall synthesis, leading to cell lysis and death of the bacteria.

Indications

  • Susceptible infections due to sensitive Gram-positive and Gram-negative bacteria
  • Respiratory tract infections
  • Skin infections
  • Urinary tract infections
  • Surgical prophylaxis

Dosage

Children: In children aged 1–11 months, the usual dose is 40 mg/kg daily in 3 divided doses, with a maximum of 1 g daily. For children aged 1

Adults: Adults typically receive 250 mg to 500 mg three times a day, with a maximum dose of 4 g per day, depending on the severity of the infection.

Mechanism of action

Cefradine, as a beta-lactam antibiotic, binds to specific penicillin-binding proteins (PBPs) located inside the bacterial cell wall. This binding inhibits the third and final stage of bacterial cell wall synthesis. Subsequently, bacterial cell lysis is mediated by autolytic enzymes such as autolysins. Cefradine disrupts the cell wall integrity, leading to bacterial death, particularly effective against Gram-positive organisms.

Pharmacodynamics

Cefradine exhibits time-dependent antibacterial activity, with a prolonged effect due to its mechanism of cell wall synthesis inhibition. Its efficacy is influenced by the concentration of the drug at the site of infection, and it shows a favorable pharmacodynamic profile against susceptible bacteria. Resistance mechanisms may include the production of beta-lactamases, alteration of PBPs, or reduced permeability of the bacterial cell wall.

Pharmacokinetics

Cefradine is well absorbed from the gastrointestinal tract, with peak plasma concentrations occurring approximately 1-2 hours after oral administration. It is distributed widely throughout body tissues and fluids, crossing the placental barrier and appearing in breast milk in low concentrations. The drug is primarily excreted unchanged in the urine, necessitating dose adjustments in patients with renal impairment. The half-life of cefradine is approximately 1-2 hours.

Adverse effects

  • Agitation
  • Confusion
  • Fatigue

Precautions

  • Dose adjustments may be necessary in renal impairment.

Pregnancy

Not known to be harmful.

Breast-feeding

Present in milk in low concentration, but appropriate to use.

Storage

Store in a cool, dry place away from light.

Formulations

  • Powder for solution for injection
  • Oral tablets
BNF 85 (British National Formulary) p.596 BNF for Children 2019-2020 p.350 PubChem / pathway

AI-synthesized from BNF references - general information only, not a substitute for professional medical advice or the current BNF. Verify doses with a pharmacist.

Molecular reference: Cefradine

PubChem CID 38103

Molecular formula: C16H19N3O4S

Mechanism of action

Cefradine is a first generation cephalosporin antibiotic with a spectrum of activity similar to Cefalexin. Cefradine, like the penicillins, is a beta-lactam antibiotic. By binding to specific penicillin-binding proteins (PBPs) located inside the bacterial cell wall, it inhibits the third and last stage of bacterial cell wall synthesis. Cell lysis is then mediated by bacterial cell wall autolytic enzymes such as autolysins; it is possible that Cefradine interferes with an autolysin inhibitor. Cephalosporins and cephamycins inhibit bacterial cell wall synthesis in a manner similar to that of penicillin. /Cephalosporins/ The first generation cephalosporins ... have activity against gram positive bacteria and relatively modest activity against gram negative microorganisms. /Cephalosporins/

Source: PubChem (NCBI) · pathways from PathBank, Reactome, WikiPathways & PharmGKB.